#Digitaltechnologies are transforming pharma's ability to meet the evolving needs of #HCPs and #patients, but the key lies in a "human led, AI-powered" approach that combines the strengths of human expertise with innovative #artificialintelligence. Inizio Engage's Thomas Mueller, Ph.D. discusses. https://lnkd.in/ecpVpqd8
pharmaphorum
Media Production
West Byfleet, Surrey 10,335 followers
Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency
About us
pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate. www.pharmaphorum.com
- Website
-
https://pharmaphorum.com/about/
External link for pharmaphorum
- Industry
- Media Production
- Company size
- 11-50 employees
- Headquarters
- West Byfleet, Surrey
- Type
- Privately Held
- Founded
- 2009
- Specialties
- pharmaceuticals, media, biotech, networking, marketing, sales, R&D, devices, diagnostics, commercial, content, communications, creative, consulting, publishing, market access, patients, digital health, and oncology
Locations
-
Primary
Rosemount House
Rosemount Avenue
West Byfleet, Surrey KT14 6LB, GB
Employees at pharmaphorum
Updates
-
NEWS: Researchers at #LeidenAcademicCentreforDrugResearch have developed 3D-printed 'mini tumours' that behave like real cancerous tissue and can be used to test new immunotherapies. #drugdiscovery #oncology https://lnkd.in/eDa9Mk2N
3D-printed tumours could aid cancer therapy R&D
pharmaphorum.com
-
NEWS: New data for #Valneva and #Pfizer's #lymedisease vaccine bolsters the case for the shot as the results of a phase 3 programme are awaited. https://lnkd.in/eY7TPFfG
Data builds behind Valneva, Pfizer's Lyme disease vaccine
pharmaphorum.com
-
NEWS: A digital version of the #NHS Health Check offered to older people in the UK will be piloted in some areas of England early next year. #digitalhealth https://lnkd.in/eNbfQ5yW
Digital NHS health checks will start in England next year
pharmaphorum.com
-
NEWS: #UNICEF has issued an emergency tender to secure #mpox vaccines for countries dealing with the brunt of the current outbreak. https://lnkd.in/euXBiS9x
As mpox cases rise over 18,000, UNICEF tenders for vaccines
pharmaphorum.com
-
Webinar Alert! Join Melanie Walsh, Takeda, and Jonah Comstock, our editor-in-chief, for a #webinar sponsored by EVERSANA INTOUCH: “Shifting the Paradigm in Pharma Marketing: Content Transformation”. Learn how to enhance your marketing strategies with innovative content. Date: Sep 25th; Time: 5pm GMT . More details here: https://lnkd.in/eBDKkAVu #PharmaMarketing #ContentTransformation
Shifting the paradigm in pharma marketing with content transformation
pharmaphorum.com
-
This week’s Top Stories from pharmaphorum is all about #marketaccess. Pfizer is following Eli Lilly and Company into the direct-to-consumer fray, while Lilly looks for ways to make its GLP-1s easier to get. Meanwhile, Johnson & Johnson wants to take proactive action against Medicare 340B abuse for its two IRA-affected drugs, but government agencies aren’t having it. Dig in below.
pharmaphorum Top Stories 2 September 2024
pharmaphorum on LinkedIn
-
NEWS: #Biotech industry body #BIA calls for new UK Chancellor to take sector-specific approach to R&D tax credits reform to tackle widespread fraud and abuse of the system. https://lnkd.in/eNacJYaB
BIA sends message to UK chancellor on R&D tax credits
pharmaphorum.com
-
NEWS: #iRhythmTechnologies' Zio XT wearable heart monitor raises #AFib diagnoses by 52%, but doesn't reduce stroke hospitalisations in GUARD-AF trial. #ESCCongress https://lnkd.in/eqRcYufD
iRhythm wearable heart monitor raises AFib diagnoses by 52%
pharmaphorum.com
-
NEWS: #Sanofi eyes filings for oral BTK inhibitor tolebrutinib for #multiplesclerosis, although two of three phase 3 trials miss their primary endpoints. https://lnkd.in/ekZiuA6T
Two of three trials fail, but Sanofi will still file MS drug
pharmaphorum.com